CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that management will participate in the following upcoming investor conferences in March:
Read more at globenewswire.comEditas Medicine to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire – Last update: